Lola Eversmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lola Eversmann has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Katharina Luttenberger
Section of Medical Psychology and Medical Sociology, Department of Psychiatry and Psychotherapy, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany
3 shared publications - Anne Radegast
Department for Psychosomatic Medicine and Psychotherapy, University for Continuing Education (UWK), Krems, Austria
2 shared publications - Leona Kind
Section of Medical Psychology and Medical Sociology, Department of Psychiatry and Pychotherapy, Uniklinikum Erlangen Friedrich‐Alexander‐Universität Erlangen‐Nürnberg (FAU) Erlangen Germany
2 shared publications - Luisa Leonie Brokmeier
Department of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany
2 shared publications - Piotr Lewczuk
Department of Neurology, Friedrich-Alexander-University and University Hospital Erlangen-Nürnberg, Erlangen, Germany
2 shared publications - Anna Eichler
Department of Child and Adolescent Mental Health, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
1 shared publication
Latest Publications
- Open Access
- 28 October 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1) , 1080
Bouldering-Psychotherapy for treating depression in adolescents (BooSt): study protocol for a randomized controlled trial
Background: Currently, there are hardly any validated group therapy programs for depressed adolescents in Germany. A recent meta-analysis confirmed a moderate antidepressant effect of exercise in adolescents with depressive symptoms. In addition, four recent systematic reviews reported positive effects of exercise interventions on psychological well-being, mood, and quality of life in adolescents with depression or depressive symptoms. We developed a manualized behavioral-therapy-based group program involving Bouldering-Psychotherapy (BPT) for adolescents (BPT-J) based on the adult version of BPT, which has already demonstrated its efficacy. The aim of the study is to evaluate the efficacy of BPT-J. Methods: The study is designed as a randomized, controlled, prospective, longitudinal, single-blind trial with two arms (BPT-J intervention group [IG], waitlist-control group [CG]). The primary aim is to investigate the efficacy of the BPT-J group therapy for adolescents for treating depressiveness. Eligible participants are adolescents with subclinical and clinical depressive symptoms between 13 and 18 years of age. The adolescents in the CG are offered participation in an identical intervention after t1. The 10-week intervention is accompanied by four data collection points for all participants: participants and their legal guardians fill out online questionnaires at the start of therapy (t0), immediately after IG therapy (t1), after CG therapy (t2), and 12 months after finalizing the intervention (follow-up, t3). In addition, structured video interviews are conducted at t0 and t1. Discussion: BooSt trial addresses the limited availability of evidence-based group interventions for adolescents with depressive symptoms in routine care. If efficacy is confirmed, BPT-J may represent a scalable, manualized, and potentially well-accepted treatment approach that could complement existing psychotherapeutic services for adolescents. Given the increasing demand and limited access to psychotherapy, the intervention may contribute to improving accessibility of mental health care. The group-based format may additionally support cost-effective implementation, reduce waiting times, facilitate peer support, and help reduce stigmatization associated with mental health treatment. Findings from the BooSt trial may further inform dissemination and implementation strategies in child and adolescent mental health care. Trial registration: ISRCTN, ISRCTN79659949, prospectively registered 19/02/2025, DOI: https://doi.org/10.1186/ISRCTN79659949 , URL: https://www.isrctn.com/ISRCTN79659949 .
- 28 October 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1) , 1080
Open AccessBouldering-Psychotherapy for treating depression in adolescents (BooSt): study protocol for a randomized controlled trial
Background: Currently, there are hardly any validated group therapy programs for depressed adolescents in Germany. A recent meta-analysis confirmed a moderate antidepressant effect of exercise in adolescents with depressive symptoms. In addition, four recent systematic reviews reported positive effects of exercise interventions on psychological well-being, mood, and quality of life in adolescents with depression or depressive symptoms. We developed a manualized behavioral-therapy-based group program involving Bouldering-Psychotherapy (BPT) for adolescents (BPT-J) based on the adult version of BPT, which has already demonstrated its efficacy. The aim of the study is to evaluate the efficacy of BPT-J. Methods: The study is designed as a randomized, controlled, prospective, longitudinal, single-blind trial with two arms (BPT-J intervention group [IG], waitlist-control group [CG]). The primary aim is to investigate the efficacy of the BPT-J group therapy for adolescents for treating depressiveness. Eligible participants are adolescents with subclinical and clinical depressive symptoms between 13 and 18 years of age. The adolescents in the CG are offered participation in an identical intervention after t1. The 10-week intervention is accompanied by four data collection points for all participants: participants and their legal guardians fill out online questionnaires at the start of therapy (t0), immediately after IG therapy (t1), after CG therapy (t2), and 12 months after finalizing the intervention (follow-up, t3). In addition, structured video interviews are conducted at t0 and t1. Discussion: BooSt trial addresses the limited availability of evidence-based group interventions for adolescents with depressive symptoms in routine care. If efficacy is confirmed, BPT-J may represent a scalable, manualized, and potentially well-accepted treatment approach that could complement existing psychotherapeutic services for adolescents. Given the increasing demand and limited access to psychotherapy, the intervention may contribute to improving accessibility of mental health care. The group-based format may additionally support cost-effective implementation, reduce waiting times, facilitate peer support, and help reduce stigmatization associated with mental health treatment. Findings from the BooSt trial may further inform dissemination and implementation strategies in child and adolescent mental health care. Trial registration: ISRCTN, ISRCTN79659949, prospectively registered 19/02/2025, DOI: https://doi.org/10.1186/ISRCTN79659949 , URL: https://www.isrctn.com/ISRCTN79659949 .
- Open Access
- 21 October 2026
- Published by Wiley in Counselling and Psychotherapy Research
- Vol. 26 (4) , e70223
Psychosocial Bouldering With Refugee and Host‐Community Adolescents in Lebanon: A Qualitative Study
Background: Adolescents in Lebanon, particularly those affected by displacement, live under challenging conditions shaped by conflict, poverty, uncertainty and disruptions to everyday life. Against this backdrop, ClimbAID developed YouCLIMB, a psychosocial bouldering intervention for adolescents from refugee and host communities. An earlier quantitative study demonstrated significant improvements in well‐being and reductions in psychological distress among participants. Building on these findings, the present qualitative study explored participants' life circumstances as context for their engagement with the intervention, perceived mechanisms of psychosocial change and the transfer of programme‐related learning to everyday life. Methods: YouCLIMB is a group‐based, 8‐week programme integrating principles of bouldering therapy and experiential education. Thirty‐eight semi‐structured interviews were conducted with adolescents from Syria, Palestine and Lebanon residing in Central Bekaa. Data were analysed with qualitative content analysis. Results: The availability of social support emerged as a key theme of participants' life circumstances, acting as either a resource or a vulnerability. Three mechanisms of change were identified: bouldering as a source of well‐being, social connection in a safe space and the development of problem‐solving and coping strategies. Participants reported multiple transfer effects, indicating that learning experiences at YouCLIMB generalised to enhance their abilities to navigate everyday challenges. Discussion: YouCLIMB offered a safe and engaging psychosocial space for fostering both individual and relational growth. As a low‐threshold intervention, structured bouldering programmes may reach adolescents with limited access to mental health and psychosocial support (MHPSS), highlighting a promising pathway for sports‐based mental health interventions in settings affected by displacement and protracted crisis. Trial Registration: All procedures were approved by the Antonine University Baabda ethics committee (approval number: 279‐2022) in February 2022, and the study was registered prospectively in April 2022 (ISRCTN13005983)
- 21 October 2026
- Published by Wiley in Counselling and Psychotherapy Research
- Vol. 26 (4) , e70223
Open AccessPsychosocial Bouldering With Refugee and Host‐Community Adolescents in Lebanon: A Qualitative Study
Background: Adolescents in Lebanon, particularly those affected by displacement, live under challenging conditions shaped by conflict, poverty, uncertainty and disruptions to everyday life. Against this backdrop, ClimbAID developed YouCLIMB, a psychosocial bouldering intervention for adolescents from refugee and host communities. An earlier quantitative study demonstrated significant improvements in well‐being and reductions in psychological distress among participants. Building on these findings, the present qualitative study explored participants' life circumstances as context for their engagement with the intervention, perceived mechanisms of psychosocial change and the transfer of programme‐related learning to everyday life. Methods: YouCLIMB is a group‐based, 8‐week programme integrating principles of bouldering therapy and experiential education. Thirty‐eight semi‐structured interviews were conducted with adolescents from Syria, Palestine and Lebanon residing in Central Bekaa. Data were analysed with qualitative content analysis. Results: The availability of social support emerged as a key theme of participants' life circumstances, acting as either a resource or a vulnerability. Three mechanisms of change were identified: bouldering as a source of well‐being, social connection in a safe space and the development of problem‐solving and coping strategies. Participants reported multiple transfer effects, indicating that learning experiences at YouCLIMB generalised to enhance their abilities to navigate everyday challenges. Discussion: YouCLIMB offered a safe and engaging psychosocial space for fostering both individual and relational growth. As a low‐threshold intervention, structured bouldering programmes may reach adolescents with limited access to mental health and psychosocial support (MHPSS), highlighting a promising pathway for sports‐based mental health interventions in settings affected by displacement and protracted crisis. Trial Registration: All procedures were approved by the Antonine University Baabda ethics committee (approval number: 279‐2022) in February 2022, and the study was registered prospectively in April 2022 (ISRCTN13005983)
- Open Access
- 27 May 2026
- Published by Springer Nature in BMC Medicine
- Vol. 24 (1) , 332
WISE-Therapy (What’s Important: Schedule and Engage) and bouldering psychotherapy for depression: A randomized clinical trial
Background: Group therapies address the growing treatment demand-supply gap for depression. This study evaluated whether the novel WISE-Therapy (WISE-T; What’s Important: Schedule and Engage) and Bouldering Psychotherapy (BPT) are more effective in reducing depressive symptoms in an outpatient group therapy setting than treatment as usual (TAU). Methods: This randomized, controlled, assessor-blinded, longitudinal, clinical trial was conducted in a naturalistic monocentric setting in Erlangen (Germany) between April 2022 and March 2023, with follow-up until July 2024. 128 adults were randomly assigned to WISE-T (44), BPT (40), or TAU (44). In 10 weekly 2-hour group sessions, WISE-T focused on identifying what is important, scheduling meaningful activities, and engaging in them for long-term mental health, and BPT combined psychotherapy with bouldering, while the control group received TAU. Depression severity was measured with the Montgomery-Asberg Depression Rating Scale at baseline, post-intervention, and one-year follow-up, and analyzed with a hybrid marginal model. Results: Both intervention groups showed significantly greater reduction in depressive symptoms than controls at post-intervention (WISE-T: -5.5 points, 95%-CI [-9.5 to -1.5], P = .007, d = 0.62; BPT: -4.2 points, 95%-CI [-8.2 to -0.3], P = .037, d = 0.48). Response rates were 35.3% for WISE-T, 29.7% for BPT, and 21.1% for controls. Remission rates were significantly higher in WISE-T (17.6%) than in controls (2.6%, P = .047). Treatment adherence was good with minimal adverse events reported. The secondary outcomes showed significant results for anxiety, sense of coherence, self-efficacy, and mindfulness during physical activity. Conclusions: Both interventions demonstrated efficacy in reducing depressive symptoms compared with controls in this single-center setting. The study supports the integration of both therapies into outpatient care settings. Trial registration: Study procedures received approval from the Friedrich-Alexander-Universität Erlangen-Nürnberg Ethics Committee (Ref. 21-332-B) on December 13, 2021. The Trial was preregistered in March 2022 via ISRCTN12347878 .
- 27 May 2026
- Published by Springer Nature in BMC Medicine
- Vol. 24 (1) , 332
Open AccessWISE-Therapy (What’s Important: Schedule and Engage) and bouldering psychotherapy for depression: A randomized clinical trial
Background: Group therapies address the growing treatment demand-supply gap for depression. This study evaluated whether the novel WISE-Therapy (WISE-T; What’s Important: Schedule and Engage) and Bouldering Psychotherapy (BPT) are more effective in reducing depressive symptoms in an outpatient group therapy setting than treatment as usual (TAU). Methods: This randomized, controlled, assessor-blinded, longitudinal, clinical trial was conducted in a naturalistic monocentric setting in Erlangen (Germany) between April 2022 and March 2023, with follow-up until July 2024. 128 adults were randomly assigned to WISE-T (44), BPT (40), or TAU (44). In 10 weekly 2-hour group sessions, WISE-T focused on identifying what is important, scheduling meaningful activities, and engaging in them for long-term mental health, and BPT combined psychotherapy with bouldering, while the control group received TAU. Depression severity was measured with the Montgomery-Asberg Depression Rating Scale at baseline, post-intervention, and one-year follow-up, and analyzed with a hybrid marginal model. Results: Both intervention groups showed significantly greater reduction in depressive symptoms than controls at post-intervention (WISE-T: -5.5 points, 95%-CI [-9.5 to -1.5], P = .007, d = 0.62; BPT: -4.2 points, 95%-CI [-8.2 to -0.3], P = .037, d = 0.48). Response rates were 35.3% for WISE-T, 29.7% for BPT, and 21.1% for controls. Remission rates were significantly higher in WISE-T (17.6%) than in controls (2.6%, P = .047). Treatment adherence was good with minimal adverse events reported. The secondary outcomes showed significant results for anxiety, sense of coherence, self-efficacy, and mindfulness during physical activity. Conclusions: Both interventions demonstrated efficacy in reducing depressive symptoms compared with controls in this single-center setting. The study supports the integration of both therapies into outpatient care settings. Trial registration: Study procedures received approval from the Friedrich-Alexander-Universität Erlangen-Nürnberg Ethics Committee (Ref. 21-332-B) on December 13, 2021. The Trial was preregistered in March 2022 via ISRCTN12347878 .